Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Prentice

Showing results (1-10 of 289) with videos related to

Pageof 29
Sort By:
Biometrics|September 1, 1976
Use of the logistic model in retrospective studiesR Prentice
Nursing Mirror|January 1, 1981
Getting the message across. Interview by Mark AllenR Prentice
Thrombosis Research. Supplement|January 1, 1990
A review of secondary coronary prevention with dipyridamole and aspirinC R Prentice
Scottish Medical Journal|October 1, 1978
Diagnosis of venous thrombosisC R Prentice
Clinics in Haematology|June 1, 1981
Myocardial infarctionC R Prentice
Haemostasis|March 9, 1999
Are symptomatic endpoints acceptable in venous thromboprophylactic studies?C R Prentice
Journal of Clinical Pathology. Supplement (Royal College of Pathologists)|January 1, 1980
Basis of antifibrinolytic therapyC R Prentice
Journal of Clinical Pathology. Supplement (Royal College of Pathologists)|January 1, 1975
Clotting and fibrinolysisC R Prentice
Thrombosis and Haemostasis|February 28, 1979
Which patients with coronary artery disease are most prone to develop a coronary artery event (presumably thrombosis)?C R Prentice
Clinics in Haematology|June 1, 1985
Acquired coagulation disordersC R Prentice
Pageof 29

Showing results (1-10 of 289) with videos related to

Sort By:
Pageof 29
Biometrics|September 1, 1976
Use of the logistic model in retrospective studiesR Prentice
Nursing Mirror|January 1, 1981
Getting the message across. Interview by Mark AllenR Prentice
Thrombosis Research. Supplement|January 1, 1990
A review of secondary coronary prevention with dipyridamole and aspirinC R Prentice
Scottish Medical Journal|October 1, 1978
Diagnosis of venous thrombosisC R Prentice
Clinics in Haematology|June 1, 1981
Myocardial infarctionC R Prentice
Haemostasis|March 9, 1999
Are symptomatic endpoints acceptable in venous thromboprophylactic studies?C R Prentice
Journal of Clinical Pathology. Supplement (Royal College of Pathologists)|January 1, 1980
Basis of antifibrinolytic therapyC R Prentice
Journal of Clinical Pathology. Supplement (Royal College of Pathologists)|January 1, 1975
Clotting and fibrinolysisC R Prentice
Thrombosis and Haemostasis|February 28, 1979
Which patients with coronary artery disease are most prone to develop a coronary artery event (presumably thrombosis)?C R Prentice
Clinics in Haematology|June 1, 1985
Acquired coagulation disordersC R Prentice
Pageof 29